News FAMHP

There are 42 result(s) found based on your search criteria

11-20 from 42 result(s)

Coronavirus: the FAMHP continues to supply essential medicinal products for intensive care and provides hospitals with daily updates

The FAMHP is addressing the concerns of healthcare professionals. To cope with the difficulties in supplying medicinal products, FAMHP experts are in constant contact with hospital pharmacies and are working tirelessly to find solutions. There is currently no shortage of medicinal products preventing the treatment of COVID-19 patients in Belgium.

COVID-19: electronic files submission

Following the recommendations of the Belgian National Security Council regarding the coronavirus epidemic, the FAMHP encourages employees to work more from home. Therefore, we ask all our partners to submit their files to us electronically as much as possible.

Coronavirus: no shortage in medication supply, FAMHP closely monitoring the situation

Following the coronavirus epidemic (COVID-19), experts at FAMHP are actively monitoring the potential impact on the availability of medication and medical devices in Belgium. The FAMHP is also supporting the European Medicines Agency (EMA) in developing COVID-19 vaccines.

The fight against anti-microbial resistance continues: the Belgian BAPCOC 2019 antibiotics guide is available on the CBIP website

As recommended by the Belgian Health Care Knowledge Centre (KCE), a new step in the fight against anti-microbial resistance has been taken: the 2019 edition of the Belgian Antibiotic Policy Coordination Committee (BAPCOC)’s antibiotics guide is available online on the Belgian Pharmacotherapy Information Centre (CBIP) website.

International week of sensitization on prudent use of antibiotics: also in veterinary medicine

18 to 24 November, 2019 is the international week of sensitization on prudent use of antibiotics. Not only in humans, but in animals too. Antibiotic use in veterinary medicine has fallen sharply in recent years, but the fight isn't over yet.

New ESVAC report: antibiotics use falls again in animal breeding in Europe. Further efforts are necessary, in Belgium as well

The European Medicines Agency (EMA) published the ninth ESVAC report (European Surveillance of Veterinary Antimicrobial Consumption) about the sale of antibacterial agents for veterinary use in 2017.

Symposium on the new European legislation on veterinary medicines.

Europe has approved new legislation on veterinary medicines and medicated animal feeds. What does this mean and what will change concretely for the industry or veterinarian?

Save the date: Symposium on the new European legislation on veterinary medicines. What will change for you?

Europe has approved new legislation on veterinary medicines and medicated animal feeds. What does this mean and what will change concretely for the industry or veterinarian? Learn everything at the FAMHP symposium on November 19.

Holders of marketing authorizations must check their data in the EMA’s article 57 database

The Vigilance Division of the FAMHP has found encoding errors in the article 57 database of the EMA. The FAMHP is asking holders of a marketing authorization for a medicine to carefully check that their registered data are correct.

Recognition of the FAMHP by the American Food and Drug Administration (FDA)

The American Food and Drug Administration (FDA) has recognised the FAMHP as its Belgian counterpart under the mutual recognition agreement (MRA) between the European Union and the United States.

11-20 from 42 result(s)